Illinois legislators recently joined California and New York in proposing bans on several food additives that a growing number of studies have shown to be harmful to human health. Read on for details and comparison of the three state bills and an update on related federal-level activity.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Royce DuBiner Royce DuBiner

Royce practices food and drug law with a focus on advising pharmaceutical, medical device, cannabis, dietary supplement, tobacco, food and beverage companies as well as investment firms on a range of regulatory matters. He is presently the lead of the Cannabis, Hemp, and…

Royce practices food and drug law with a focus on advising pharmaceutical, medical device, cannabis, dietary supplement, tobacco, food and beverage companies as well as investment firms on a range of regulatory matters. He is presently the lead of the Cannabis, Hemp, and CBD industry team.

Photo of Trent Taylor Trent Taylor

Trent is co-chair of the firm’s Consumer Products & Retail industry team. He focuses on defending complex class actions with an emphasis on product class actions, public and private nuisance litigation, environmental contamination suits, and food, cosmetic, and supplement labeling (including CBD) and…

Trent is co-chair of the firm’s Consumer Products & Retail industry team. He focuses on defending complex class actions with an emphasis on product class actions, public and private nuisance litigation, environmental contamination suits, and food, cosmetic, and supplement labeling (including CBD) and safety issues.

Photo of Allyson Maur Allyson Maur

Allyson advises on regulatory issues affecting diagnostics developers, biopharma manufacturers, and clinical laboratories, including CLIA/CLEP and FDA regulatory advice, MLR and MRC review of marketing and promotional materials, clinical studies, global data privacy issues, ethics & compliance, commercial contracting, commercial litigation and more.

Allyson advises on regulatory issues affecting diagnostics developers, biopharma manufacturers, and clinical laboratories, including CLIA/CLEP and FDA regulatory advice, MLR and MRC review of marketing and promotional materials, clinical studies, global data privacy issues, ethics & compliance, commercial contracting, commercial litigation and more.

Photo of Gregory Bales Gregory Bales

Before joining the firm, Greg Bales worked for U.S. Senate Majority Whip Richard J. Durbin for more than a decade, serving as senior advisor in the Senator’s government office as well as his campaign manager for his 2020 reelection. During his time with…

Before joining the firm, Greg Bales worked for U.S. Senate Majority Whip Richard J. Durbin for more than a decade, serving as senior advisor in the Senator’s government office as well as his campaign manager for his 2020 reelection. During his time with the Senator, he oversaw special projects throughout Illinois, and worked as a liaison to elected officials, businesses, community organizations, and other constituencies across the state.

Photo of Kent Gaffney Kent Gaffney

Kent joined McGuireWoods Consulting in January 2013 and serves as a senior vice president of State Government Relations. His primary areas of service include assisting clients with legislative, appropriations and regulatory needs.

Photo of Henry Mohn Henry Mohn

Henry Mohn joined McGuireWoods Consulting in March 2021 as research associate in the firm’s Illinois government relations team. In this role, he supports the team and clients with legislative and administrative rule tracking, media monitoring, procurement, budget analysis, association management, event planning, and…

Henry Mohn joined McGuireWoods Consulting in March 2021 as research associate in the firm’s Illinois government relations team. In this role, he supports the team and clients with legislative and administrative rule tracking, media monitoring, procurement, budget analysis, association management, event planning, and a variety of other research projects.